Wells Fargo analyst Mohit Bansal downgraded Vertex Pharmaceuticals (VRTX) to Equal Weight from Overweight with an unchanged price target of ...

LivaNova (LIVN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael Matson from ...

Perrigo is exploring new markets with a 'disruptive growth' team, focusing on women's health and GLP-1 side effect relief.

Porinju Veliyath's firm acquired a 0.51 percent stake in Greaves Cotton for ₹29.37 crore. The stock jumped 5 percent after ...

Paula Ragan, the President and CEO of X4 Pharmaceuticals, Inc. (NASDAQ:XFOR), recently sold 76,473 shares of the company's common stock. The shares were sold at a weighted average price of $0.454 per ...

Praveg, known for its eco-friendly luxury accommodations, experienced a remarkable stock increase of 29,814% over five years.